Skip to main content
Top
Published in: Inflammation 3/2015

01-06-2015

Histamine H3 and H4 Receptor Ligands Modify Vascular Histamine Levels in Normal and Arthritic Large Blood Vessels In Vivo

Authors: Konstantinos Kyriakidis, Evangelia Zampeli, Marina Palaiologou, Dina Tiniakos, Ekaterini Tiligada

Published in: Inflammation | Issue 3/2015

Login to get access

Abstract

Growing evidence associates histamine with arthritis, but its implication in shaping vascular function in chronic inflammation remains largely elusive. This study explored the involvement of vascular histamine in the extra-articular responses in peripheral large blood vessels using a rat model of adjuvant-induced arthritis. Histamine levels were increased in the abdominal aorta and the inferior vena cava of arthritic animals. Contrary to the H1 receptor antagonist dimetindene, histamine induction was observed following administration of the H3 and H4 receptor ligands GSK334429 and JNJ7777120, respectively. In arthritis, prophylactic treatment with GSK334429 partially attenuated the clinical signs and restored basal histamine levels only in the abdominal aorta. This study is the first to implicate the H3 and H4 receptors in a concerted constitutive regulation of basal vascular histamine in the rat large blood vessels and to identify the H3 receptor as a component that may influence arterial histamine during the onset of arthritis.
Literature
1.
go back to reference Parsons, M.E., and C.R. Ganellin. 2006. Histamine and its receptors. British Journal of Pharmacology 147(S1): 127–125.CrossRef Parsons, M.E., and C.R. Ganellin. 2006. Histamine and its receptors. British Journal of Pharmacology 147(S1): 127–125.CrossRef
2.
go back to reference Kakavas, S., E. Zampeli, K. Papamichael, B. Delitheos, and E. Tiligada. 2006. The mast cell pathway to inflammation and homeostasis: Pharmacological insights. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 5: 323–324.CrossRef Kakavas, S., E. Zampeli, K. Papamichael, B. Delitheos, and E. Tiligada. 2006. The mast cell pathway to inflammation and homeostasis: Pharmacological insights. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 5: 323–324.CrossRef
3.
go back to reference Tiligada, E., E. Zampeli, K. Sander, and H. Stark. 2009. Histamine H3 and H4 receptors as novel drug targets. Expert Opinion on Investigational Drugs 18: 1519–1531.CrossRefPubMed Tiligada, E., E. Zampeli, K. Sander, and H. Stark. 2009. Histamine H3 and H4 receptors as novel drug targets. Expert Opinion on Investigational Drugs 18: 1519–1531.CrossRefPubMed
4.
go back to reference Tiligada, E., K. Kyriakidis, P.L. Chazot, and M.B. Passani. 2011. Histamine pharmacology and new CNS drug targets. CNS Neuroscience & Therapeutics 17: 620–628.CrossRef Tiligada, E., K. Kyriakidis, P.L. Chazot, and M.B. Passani. 2011. Histamine pharmacology and new CNS drug targets. CNS Neuroscience & Therapeutics 17: 620–628.CrossRef
5.
go back to reference Zampeli, E., and E. Tiligada. 2009. The role of histamine H4 receptor in immune and inflammatory disorders. British Journal of Pharmacology 157: 24–33.CrossRefPubMedCentralPubMed Zampeli, E., and E. Tiligada. 2009. The role of histamine H4 receptor in immune and inflammatory disorders. British Journal of Pharmacology 157: 24–33.CrossRefPubMedCentralPubMed
6.
go back to reference Sasaguri, Y., K.Y. Wang, A. Tanimoto, et al. 2005. Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circulation Research 96: 974–981.CrossRefPubMed Sasaguri, Y., K.Y. Wang, A. Tanimoto, et al. 2005. Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circulation Research 96: 974–981.CrossRefPubMed
7.
go back to reference Sun, P., X. Jin, T. Koyama, S. Li, Y. Kitamura, and H. Kawasaki. 2010. R-(−)-alpha-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteries. Biological and Pharmaceutical Bulletin 33: 58–63.CrossRefPubMed Sun, P., X. Jin, T. Koyama, S. Li, Y. Kitamura, and H. Kawasaki. 2010. R-(−)-alpha-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteries. Biological and Pharmaceutical Bulletin 33: 58–63.CrossRefPubMed
8.
go back to reference Malinowska, B., G. Godlewski, and E. Schlicker. 1998. Histamine H3 receptors—general characterization and their function in the cardiovascular system. Journal of Physiology and Pharmacology 49: 191–211.PubMed Malinowska, B., G. Godlewski, and E. Schlicker. 1998. Histamine H3 receptors—general characterization and their function in the cardiovascular system. Journal of Physiology and Pharmacology 49: 191–211.PubMed
9.
go back to reference Martín-Martínez, M.A., C. González-Juanatey, S. Castañeda, et al. 2014. Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion. Seminars in Arthritis and Rheumatism 44: 1–8.CrossRefPubMed Martín-Martínez, M.A., C. González-Juanatey, S. Castañeda, et al. 2014. Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: Scientific evidence and expert opinion. Seminars in Arthritis and Rheumatism 44: 1–8.CrossRefPubMed
10.
go back to reference Ohki, E., M. Suzuki, T. Aoe, Y. Ikawa, E. Negishi, and K. Ueno. 2007. Expression of histamine H4 receptor in synovial cells from rheumatoid arthritic patients. Biological and Pharmaceutical Bulletin 30: 2217–2220.CrossRefPubMed Ohki, E., M. Suzuki, T. Aoe, Y. Ikawa, E. Negishi, and K. Ueno. 2007. Expression of histamine H4 receptor in synovial cells from rheumatoid arthritic patients. Biological and Pharmaceutical Bulletin 30: 2217–2220.CrossRefPubMed
11.
go back to reference Grzybowska-Kowalczyk, A., D. Maslinska, M. Wojciechowska, et al. 2008. Expression of histamine H4 receptor in human osteoarthritic synovial tissue. Inflammation Research 57(S1): 63–64.CrossRef Grzybowska-Kowalczyk, A., D. Maslinska, M. Wojciechowska, et al. 2008. Expression of histamine H4 receptor in human osteoarthritic synovial tissue. Inflammation Research 57(S1): 63–64.CrossRef
12.
go back to reference Cowden, J.M., F. Yu, H. Banie, et al. 2014. The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Annals of the Rheumatic Diseases 73: 600–608.CrossRefPubMedCentralPubMed Cowden, J.M., F. Yu, H. Banie, et al. 2014. The histamine H4 receptor mediates inflammation and Th17 responses in preclinical models of arthritis. Annals of the Rheumatic Diseases 73: 600–608.CrossRefPubMedCentralPubMed
13.
go back to reference Medhurst, A.D., M.A. Briggs, G. Bruton, et al. 2007. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats. Biochemical Pharmacology 73: 1182–1194.CrossRefPubMed Medhurst, A.D., M.A. Briggs, G. Bruton, et al. 2007. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats. Biochemical Pharmacology 73: 1182–1194.CrossRefPubMed
14.
go back to reference Cowart, M., G. Hsieh, L.A. Black, et al. 2012. Pharmacological characterization of A-960656, a histamine H3 receptor antagonist with efficacy in animal models of osteoarthritis and neuropathic pain. European Journal of Pharmacology 684: 87–94.CrossRefPubMed Cowart, M., G. Hsieh, L.A. Black, et al. 2012. Pharmacological characterization of A-960656, a histamine H3 receptor antagonist with efficacy in animal models of osteoarthritis and neuropathic pain. European Journal of Pharmacology 684: 87–94.CrossRefPubMed
15.
go back to reference Abd-Allah, A.R., S.F. Ahmad, I. Alrashidi, et al. 2014. Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis. International Immunology 26: 325–340.CrossRefPubMed Abd-Allah, A.R., S.F. Ahmad, I. Alrashidi, et al. 2014. Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritis. International Immunology 26: 325–340.CrossRefPubMed
16.
go back to reference Adlesic, M., M. Verdrengh, M. Bokarewa, L. Dahlberg, S.J. Foster, and A. Tarkowski. 2007. Histamine in rheumatoid arthritis. Scandinavian Journal of Immunology 65: 530–537.CrossRefPubMed Adlesic, M., M. Verdrengh, M. Bokarewa, L. Dahlberg, S.J. Foster, and A. Tarkowski. 2007. Histamine in rheumatoid arthritis. Scandinavian Journal of Immunology 65: 530–537.CrossRefPubMed
17.
go back to reference Thurmond, R.L., P.J. Desai, P.J. Dunford, et al. 2004. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. Journal of Pharmacology and Experimental Therapeutics 309: 404–413.CrossRefPubMed Thurmond, R.L., P.J. Desai, P.J. Dunford, et al. 2004. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. Journal of Pharmacology and Experimental Therapeutics 309: 404–413.CrossRefPubMed
18.
go back to reference Zampeli, E., R.L. Thurmond, and E. Tiligada. 2009. The histamine H4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva. Inflammation Research 58: 285–291.CrossRefPubMed Zampeli, E., R.L. Thurmond, and E. Tiligada. 2009. The histamine H4 receptor antagonist JNJ7777120 induces increases in the histamine content of the rat conjunctiva. Inflammation Research 58: 285–291.CrossRefPubMed
19.
go back to reference Hofstra, C.L., P.J. Desai, R.L. Thurmond, and W.P. Fung-Leung. 2003. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. Journal of Pharmacology and Experimental Therapeutics 305: 1212–1221.CrossRefPubMed Hofstra, C.L., P.J. Desai, R.L. Thurmond, and W.P. Fung-Leung. 2003. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. Journal of Pharmacology and Experimental Therapeutics 305: 1212–1221.CrossRefPubMed
20.
go back to reference Tiligada, E. 2012. Editorial: Is histamine the missing link in chronic inflammation? Journal of Leukocyte Biology 92: 4–6.CrossRefPubMed Tiligada, E. 2012. Editorial: Is histamine the missing link in chronic inflammation? Journal of Leukocyte Biology 92: 4–6.CrossRefPubMed
21.
go back to reference Fang, Z.Y., J. Fontaine, P. Unger, and G. Berkenboom. 1991. Alterations of the endothelial function of isolated aortae in rats with adjuvant arthritis. Archives Internationales de Pharmacodynamie et de Thérapie 311: 122–130.PubMed Fang, Z.Y., J. Fontaine, P. Unger, and G. Berkenboom. 1991. Alterations of the endothelial function of isolated aortae in rats with adjuvant arthritis. Archives Internationales de Pharmacodynamie et de Thérapie 311: 122–130.PubMed
22.
go back to reference Inglis, J.J., A. Nissim, D.M. Lees, S.P. Hunt, Y. Chernajovsky, and B.L. Kidd. 2005. The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation. Arthritis Research and Therapy 7: R807–816.CrossRefPubMedCentralPubMed Inglis, J.J., A. Nissim, D.M. Lees, S.P. Hunt, Y. Chernajovsky, and B.L. Kidd. 2005. The differential contribution of tumour necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation. Arthritis Research and Therapy 7: R807–816.CrossRefPubMedCentralPubMed
23.
go back to reference Coruzzi, G., C. Pozzoli, M. Adami, et al. 2012. Strain-dependent effects of the histamine H4 receptor antagonist JNJ7777120 in a murine model of acute skin inflammation. Experimental Dermatology 21: 32–37.CrossRefPubMed Coruzzi, G., C. Pozzoli, M. Adami, et al. 2012. Strain-dependent effects of the histamine H4 receptor antagonist JNJ7777120 in a murine model of acute skin inflammation. Experimental Dermatology 21: 32–37.CrossRefPubMed
24.
go back to reference Nijmeijer, S., H.F. Vischer, F. Sirci, et al. 2013. Detailed analysis of biased histamine H4 receptor signalling by JNJ 7777120 analogues. British Journal of Pharmacology 170: 78–88.CrossRefPubMedCentralPubMed Nijmeijer, S., H.F. Vischer, F. Sirci, et al. 2013. Detailed analysis of biased histamine H4 receptor signalling by JNJ 7777120 analogues. British Journal of Pharmacology 170: 78–88.CrossRefPubMedCentralPubMed
25.
go back to reference Nordemann, U., D. Wifling, D. Schnell, et al. 2013. Luciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: Correlations and discrepancies between distal and proximal readouts. PloS One 8: e73961.CrossRefPubMedCentralPubMed Nordemann, U., D. Wifling, D. Schnell, et al. 2013. Luciferase reporter gene assay on human, murine and rat histamine H4 receptor orthologs: Correlations and discrepancies between distal and proximal readouts. PloS One 8: e73961.CrossRefPubMedCentralPubMed
26.
go back to reference Takenaga, M., H. Kawasaki, A. Wada, and T. Eto. 1995. Calcitonin gene-related peptide mediates acetylcholine-induced endothelium-independent vasodilation in mesenteric resistance blood vessels of the rat. Circulation Research 76: 935–941.CrossRefPubMed Takenaga, M., H. Kawasaki, A. Wada, and T. Eto. 1995. Calcitonin gene-related peptide mediates acetylcholine-induced endothelium-independent vasodilation in mesenteric resistance blood vessels of the rat. Circulation Research 76: 935–941.CrossRefPubMed
27.
go back to reference Tiligada, E., D. Aslanis, A. Delitheos, and D. Varonos. 2000. Changes in histamine content following pharmacologically-induced mast cell degranulation in the rat conjunctiva. Pharmacological Research 41: 667–670.CrossRefPubMed Tiligada, E., D. Aslanis, A. Delitheos, and D. Varonos. 2000. Changes in histamine content following pharmacologically-induced mast cell degranulation in the rat conjunctiva. Pharmacological Research 41: 667–670.CrossRefPubMed
28.
go back to reference Pusztaszeri, M.P., W. Seelentag, and F.T. Bosman. 2006. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. The Journal of Histochemistry and Cytochemistry 54: 385–395.CrossRefPubMed Pusztaszeri, M.P., W. Seelentag, and F.T. Bosman. 2006. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. The Journal of Histochemistry and Cytochemistry 54: 385–395.CrossRefPubMed
29.
go back to reference Galajda, Z., J. Balla, A.J. Szentmiklosi, et al. 2011. Histamine and H1-histamine receptors faster venous circulation. Journal of Cellular and Molecular Medicine 15: 2614–2623.CrossRefPubMedCentralPubMed Galajda, Z., J. Balla, A.J. Szentmiklosi, et al. 2011. Histamine and H1-histamine receptors faster venous circulation. Journal of Cellular and Molecular Medicine 15: 2614–2623.CrossRefPubMedCentralPubMed
30.
go back to reference Binstadt, B.A., P.R. Patel, H. Alencar, et al. 2006. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nature Immunology 7: 284–292.CrossRefPubMed Binstadt, B.A., P.R. Patel, H. Alencar, et al. 2006. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nature Immunology 7: 284–292.CrossRefPubMed
31.
go back to reference Blanchet, M.R., M. Gold, S. Maltby, et al. 2010. Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability. Journal of Immunology 184: 1292–1299.CrossRef Blanchet, M.R., M. Gold, S. Maltby, et al. 2010. Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability. Journal of Immunology 184: 1292–1299.CrossRef
32.
go back to reference Tippens, A.S., S.V. Davis, J.R. Hayes, E.C. Bryda, T.L. Green, and C.A. Gruetter. 2004. Detection of histidine decarboxylase in rat aorta and cultured rat aortic smooth muscle cells. Inflammation Research 53: 390–395.PubMed Tippens, A.S., S.V. Davis, J.R. Hayes, E.C. Bryda, T.L. Green, and C.A. Gruetter. 2004. Detection of histidine decarboxylase in rat aorta and cultured rat aortic smooth muscle cells. Inflammation Research 53: 390–395.PubMed
33.
go back to reference Gruetter, C.A., B. Bailey, L. Easterling, and J.L. Szarek. 2002. Release of non-mast cell histamine from rat aorta. Life Sciences 70: 1709–1717.CrossRefPubMed Gruetter, C.A., B. Bailey, L. Easterling, and J.L. Szarek. 2002. Release of non-mast cell histamine from rat aorta. Life Sciences 70: 1709–1717.CrossRefPubMed
34.
go back to reference Stegaev, V., A.T. Nies, P. Porola, et al. 2013. Histamine transport and metabolism are deranged in salivary glands in Sjogren’s syndrome. Rheumatology 52: 1599–1608.CrossRefPubMed Stegaev, V., A.T. Nies, P. Porola, et al. 2013. Histamine transport and metabolism are deranged in salivary glands in Sjogren’s syndrome. Rheumatology 52: 1599–1608.CrossRefPubMed
35.
go back to reference Saligrama, N., L.K. Case, R. del Rio, R. Noubade, and C. Teuscher. 2013. Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis. Journal of Immunology 191: 614–622.CrossRef Saligrama, N., L.K. Case, R. del Rio, R. Noubade, and C. Teuscher. 2013. Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis. Journal of Immunology 191: 614–622.CrossRef
36.
go back to reference Kyriakidis, D.Α., and E. Tiligada. 2013. Non receptor-mediated histamine actions. In Histamine H 4 receptor: A novel drug target for immunoregulation and inflammation, ed. H. Stark, 309–32. London: Versita. Kyriakidis, D.Α., and E. Tiligada. 2013. Non receptor-mediated histamine actions. In Histamine H 4 receptor: A novel drug target for immunoregulation and inflammation, ed. H. Stark, 309–32. London: Versita.
37.
go back to reference Krementsov, D.N., E.H. Wall, R.A. Martin, et al. 2013. Histamine h3 receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility. PloS One 8: e62743.CrossRefPubMedCentralPubMed Krementsov, D.N., E.H. Wall, R.A. Martin, et al. 2013. Histamine h3 receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility. PloS One 8: e62743.CrossRefPubMedCentralPubMed
38.
go back to reference Tiligada, E. 2013. Perspectives in H4R research and therapeutic exploitation. In Histamine H 4 receptor: A novel drug target for immunoregulation and inflammation, ed. H. Stark, 333–52. London: Versita. Tiligada, E. 2013. Perspectives in H4R research and therapeutic exploitation. In Histamine H 4 receptor: A novel drug target for immunoregulation and inflammation, ed. H. Stark, 333–52. London: Versita.
Metadata
Title
Histamine H3 and H4 Receptor Ligands Modify Vascular Histamine Levels in Normal and Arthritic Large Blood Vessels In Vivo
Authors
Konstantinos Kyriakidis
Evangelia Zampeli
Marina Palaiologou
Dina Tiniakos
Ekaterini Tiligada
Publication date
01-06-2015
Publisher
Springer US
Published in
Inflammation / Issue 3/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-0057-1

Other articles of this Issue 3/2015

Inflammation 3/2015 Go to the issue